Clinical Study of the Topcon Tonometer TRK-3

July 19, 2022 updated by: Topcon Corporation

Clinical Study of the Topcon Tonometer TRK-3 to Demonstrate Conformance to ISO 8612, JIS T7312, and ANSI Z80.10-2014 Ophthalmic Instruments - Tonometers

The study will assess the TRK-3 for conformity to ISO 8612:2009, JIS T7312:2015, and ANSI Z80.10-2014 Ophthalmic Instruments - Tonometers, to the FDA Guidance for Industry and FDA Staff, Tonometer-Premarket Notification [510(k)] Submissions, and the applicable Supplemental Information Sheet.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

139

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tokyo, Japan
        • Kato Eye Clinic
      • Tokyo, Japan
        • Seiyo Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Subjects undergoing routine eye exam at eye care clinic

Description

Inclusion Criteria:

  1. Be 18 years of age or older at the time of informed consent
  2. Irrespective of sex
  3. Irrespective of race or ethnicity
  4. Be willing and able to provide written informed consent by subject or legally designated representative prior to any study procedures

Exclusion Criteria:

  1. Have only one functional eye
  2. Have one eye with poor or eccentric fixation
  3. Have corneal scarring or have had corneal surgery, including corneal laser surgery in either eye
  4. Have microphthalmos in either eye
  5. Have buphthalmos in either eye
  6. Be a contact lens wearer (persons wearing soft contact lenses within the past 3 months and/or hard contact lenses within the past 6 months)
  7. Have dry eyes (persons who have been diagnosed by a physician and are currently using prescription drugs or routinely using artificial tears)
  8. Uncontrollably blink, squint, wink, twitch or squeeze eye(s) - blepharospasm
  9. Have nystagmus in either eye
  10. Have keratoconus in either eye
  11. Have any other corneal or conjunctival pathology or infection in either eye
  12. Have central corneal thickness is less than 500μm or more than 600μm
  13. Be allergic to eye drop anesthetics
  14. Be allergic to sodium fluorescein

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
fluid pressure inside the eye (intraocular pressure) measured in millimeters of mercury (mm Hg)
Time Frame: 1 day
Intraocular Pressure (IOP) measurements acquired with the study tonometer are compared to the reference tonometer IOP measurements to demonstrate that they meet the requirement specified in the tonometer standards (ISO 8612:2009, JIS T7312:2015 and ANSI Z80.10-2014)
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 11, 2021

Primary Completion (ACTUAL)

January 14, 2022

Study Completion (ACTUAL)

January 14, 2022

Study Registration Dates

First Submitted

November 8, 2021

First Submitted That Met QC Criteria

December 21, 2021

First Posted (ACTUAL)

December 22, 2021

Study Record Updates

Last Update Posted (ACTUAL)

July 20, 2022

Last Update Submitted That Met QC Criteria

July 19, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • THQ-2021-04

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intraocular Pressure

Clinical Trials on tonometer

3
Subscribe